Related Experiment Video
Updated: Jun 27, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
Lysosome-targeting chimeras enable targeted protein degradation.
Bozhao Li1, Yanyan Li2, Jian Zhang3
1Institutes of Biomedical Sciences, Inner Mongolia University, Hohhot 010070, China; Institute of Nanotechnology and Intelligence (inAI), Jinan University, Guangzhou 510632, China.
Lysosome-targeting chimeras (LYTACs) offer a novel way to degrade extracellular proteins for therapeutic benefit. This review details LYTAC mechanisms, receptor engagement, and challenges for next-generation drug development.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Targeted protein degradation (TPD) is a key therapeutic strategy.
- Lysosome-targeting chimeras (LYTACs) degrade extracellular and membrane proteins.
- LYTACs utilize receptor-mediated endocytosis for lysosomal delivery.
Purpose of the Study:
- Provide a mechanistic and conceptual overview of LYTAC technology.
- Classify LYTACs based on ligand architecture and receptor engagement.
- Discuss translational challenges and future design strategies for LYTAC therapeutics.
Main Methods:
- Review of LYTAC molecular classification.
- Analysis of lysosome-targeting receptor roles (e.g., CI-M6PR, ASGPR).
- Examination of endocytic trafficking and lysosomal processing pathways.
Main Results:
- Receptor choice significantly impacts LYTAC internalization and degradation.
- Key determinants for target recognition and intracellular routing identified.
- Major translational hurdles include tissue selectivity, pharmacokinetics, and immunogenicity.
Conclusions:
- LYTACs represent a promising TPD modality for challenging protein targets.
- Emerging design strategies aim to enhance precision and clinical potential.
- Overcoming translational challenges is crucial for next-generation LYTAC therapeutics.
More Related Videos
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Lysosomes
Lysosomal Hydrolases
Export of Misfolded Proteins out of the ER
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...

